US-listed Hoth Therapeutics announced that the company's board of directors has approved the purchase of up to $1 million in bitcoin. Robb Knie, CEO of Hoth, said: "As bitcoin continues to grow and gradually becomes a major asset class, attracting the attention and recognition of investors, we believe bitcoin will become a strong fiscal reserve asset.